Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Darnige

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Plos One|August 30, 2019
Pain assessment and factors influencing pain during bone marrow aspiration: A prospective studyNicolas Gendron, Sara Zia Chahabi, Géraldine Poenou, et al.
Clinical and Experimental Rheumatology|December 23, 2024
Positivity of antiphosphatidylserine/prothrombin antibodies identifies a subgroup of more severe antiphospholipid syndrome patientsAudrey Delarue, Luc Darnige, Alexis F Guedon, et al.
Thrombosis Research|November 12, 2019
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulantsGeorges Jourdi, Maxime Delrue, Alain Stepanian, et al.
Annals of Hematology|August 25, 2019
Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled studyTessa Huscenot, Luc Darnige, Orianne Wagner-Ballon, et al.
Autoimmunity Reviews|April 14, 2015
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndromeNicolas Noel, Fabien Dutasta, Nathalie Costedoat-Chalumeau, et al.
Plos One|February 4, 2010
Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patientsValerie Ugo, Sylvie Tondeur, Marie-Laurence Menot, et al.
Haematologica|July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutationsBruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital MortalityNicolas Gendron, Marie-Agnès Dragon-Durey, Richard Chocron, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Plos One|August 30, 2019
Pain assessment and factors influencing pain during bone marrow aspiration: A prospective studyNicolas Gendron, Sara Zia Chahabi, Géraldine Poenou, et al.
Clinical and Experimental Rheumatology|December 23, 2024
Positivity of antiphosphatidylserine/prothrombin antibodies identifies a subgroup of more severe antiphospholipid syndrome patientsAudrey Delarue, Luc Darnige, Alexis F Guedon, et al.
Thrombosis Research|November 12, 2019
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulantsGeorges Jourdi, Maxime Delrue, Alain Stepanian, et al.
Annals of Hematology|August 25, 2019
Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled studyTessa Huscenot, Luc Darnige, Orianne Wagner-Ballon, et al.
Autoimmunity Reviews|April 14, 2015
Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndromeNicolas Noel, Fabien Dutasta, Nathalie Costedoat-Chalumeau, et al.
Plos One|February 4, 2010
Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patientsValerie Ugo, Sylvie Tondeur, Marie-Laurence Menot, et al.
Haematologica|July 9, 2026
Genetic screening of triple negative thrombocytosis patients identifies germline <i>MPL</i> compound mutations and <i>SH2B3/LNK</i> truncating mutationsBruno Cassinat, Louise Lecordier, Sarah Awan-Toor, et al.
Research and Practice in Thrombosis and Haemostasis|March 24, 2025
Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemicNicolas Gendron, Dominique Helley, Johannes Thaler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2021
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital MortalityNicolas Gendron, Marie-Agnès Dragon-Durey, Richard Chocron, et al.
Pageof 4